...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Cancer research derailed by nearly two years due to COVID-19, scientists say.

The opener:

 

LONDON — For many people around the world, the 2020s feel like “lost” years so far. While science may be at the forefront of the pandemic, scientists say other fields of study are falling behind. A new report even warns that advances in cancer research are suffering due to COVID-19. With less funding and quarantine mandates, a team from the Institute of Cancer Research in London believe some cancer breakthroughs are now two years behind schedule.

“The coronavirus pandemic has posed the greatest threat to cancer research in generations,” Professor Paul Workman says in a release.

 

https://www.studyfinds.org/cancer-research-delay-two-years/

Share
New Message
Please login to post a reply